---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-024872"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-08-19T23:59:59+00:00"
generated_at: "2026-05-17T11:25:58.394442+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma prices $4M public offering, uplists to Nasdaq; appoints two independent directors

## Summary
- Raised $4M gross ($3.34M net) via public offering of 1M shares at $4.00/sh; underwriters have 45-day option for 150K more.
- Common stock began trading on Nasdaq Capital Market on Aug 15 under symbol PPCB, uplisted from OTC Pink.
- Appointed Joseph Himy and Annie VanBroekhoven as independent directors on Aug 14; serving on audit, compensation, nominating committees.
- Issued Representative's warrants to D. Boral Capital for 30,000 shares at $4.00, exercisable from Feb 2026 to Aug 2030.

## SEC filing metadata
- accession: 0001641172-25-024872
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-08-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000164117225024872/0001641172-25-024872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225024872/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-024872
- JSON: https://secwatch.observer/filing/0001641172-25-024872.json
- Plain text: https://secwatch.observer/filing/0001641172-25-024872.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.